Related Experiment Videos

Genotype-phenotype relations for the Parkinson's disease genes SNCA, LRRK2, VPS35: MDSGene systematic review

Joanne Trinh1, Florentine M J Zeldenrust2, Jana Huang2

  • 1Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.

Insights

This review examines three dominant forms of Parkinson disease (PD), focusing on SNCA, LRRK2, and VPS35 mutations. It confirms SNCA mutations lead to earlier onset and psychiatric symptoms compared to LRRK2 and VPS35.

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Parkinson disease (PD) has genetic forms, including autosomal-dominant types.
  • Understanding genotype-phenotype correlations is crucial for PD management.
  • MDSGene provides a platform for curated genetic and phenotypic data.

Purpose of the Study:

  • To review and synthesize data on three major autosomal-dominant Parkinson disease forms: SNCA, LRRK2, and VPS35.
  • To analyze phenotypic and genotypic data from 937 patients with 44 distinct mutations.
  • To provide an accessible, searchable database of this information.

Main Methods:

  • Systematic literature review following MDSGene's protocol.
  • Screening of 2,972 citations for relevant data.
  • Curation of phenotypic and genotypic data from 937 patients.

Main Results:

  • Confirmed later disease onset (median ~49 years) for dominant PD compared to recessive forms.
  • SNCA mutation carriers exhibit earlier onset than LRRK2 and VPS35 carriers (P < 0.001).
  • Identified distinct clinical features: psychiatric symptoms in SNCA, typical PD in LRRK2, and good l-dopa response in VPS35.

Conclusions:

  • Autosomal-dominant PD forms linked to SNCA, LRRK2, and VPS35 have specific clinical and genetic profiles.
  • The MDSGene database offers a valuable resource for researchers studying these PD subtypes.
  • Further research is needed to address data gaps in phenotypic and genotypic reporting.

Related Concept Videos